This study presents a novel mathematical model that captures the co-dynamics of pulmonary tuberculosis in the presence of opportunistic pneumonia. The model integrates opportunistic pneumonia into the classical pulmonary tuberculosis transmission framework, based on clinical evidence of a lethal synergism between the two diseases. A Holling-type saturation function is utilized to reflect the impact of natural immunity on the progression from latent tuberculosis infection to active disease. Asymptomatic infectious individuals can transmit the infection unnoticed, thereby significantly contributing to the high rate of transmission. Thus, the screening of asymptomatic individuals is incorporated into the model as a strategy to mitigate the prevalence of co-infections. A comprehensive sensitivity analysis and numerical simulations were conducted to evaluate the effects of various interventions, including enhancing natural immunity, screening asymptomatic and latently infected individuals, improving vaccine efficacy, and treating patients with severe pulmonary tuberculosis. The sensitivity analysis reveals that improving vaccine efficacy is the most effective strategy for minimizing co-infections. Simulations also demonstrate that increased screening and treatment rates significantly reduce the burden of pulmonary tuberculosis-pneumonia co-infections. These results underscore the need to develop vaccines with higher efficacy to reduce co-infections of pulmonary tuberculosis and opportunistic pneumonia. Additionally, the study recommends expanded screening of asymptomatic tuberculosis cases and the strengthening of immunity among latently infected populations.
Published in | Applied and Computational Mathematics (Volume 14, Issue 4) |
DOI | 10.11648/j.acm.20251404.15 |
Page(s) | 223-241 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2025. Published by Science Publishing Group |
Pulmonary Tuberculosis, Asymptomatic Infectious, Opportunistic Pneumonia, Latently Infected, Natural Immunity, Numerical Simulation
[1] | World Health Organization. (2023). Global tuberculosis report 2023. Retrieved May 10, 2025, from |
[2] |
National Tuberculosis, Leprosy and Lung Disease Program. 2023 Annual Report. Ministry of Health, Kenya. Retrieved May 21, 2025, from
https://nltp.co.ke/wp-content/uploads/2025/03/2023-Annual-Report.pdf |
[3] | Ullah, N., Fusco, L., Ametrano, L., Bartalucci, C., Giacobbe, D. R., Vena, A., & Bassetti, M. (2025). Diagnostic Approach to Pneumonia in Immunocompromised Hosts. Journal of Clinical Medicine, 14(2), 389. |
[4] | Gweryina, R. I., Madubueze, C. E., Bajiya, V. P., & Esla, F. E. (2023). Modeling and analysis of tuberculosis and pneumonia co-infection dynamics with cost-effective strategies. Results in Control and Optimization, 10, 100210. |
[5] | Baguelin, M., Medley, G. F., Nightingale, E. S., O’Reilly, K. M., Rees, E. M., Waterlow, N. R., & Wagner, M. (2020). Tooling-up for infectious disease transmission modelling. Epidemics, 32, 100395. |
[6] | Yan, P., & Chowell, G. (2019). Quantitative methods for investigating infectious disease outbreaks (Vol. 70). Cham, Switzerland: Springer. |
[7] |
World Health Organization. (2023). Tuberculosis fact sheet. Retrieved May 14, 2025, from
https://www.who.int/news-room/fact-sheets/detail/tuberculosis |
[8] | Chandra, P., Grigsby, S. J., & Philips, J. A. (2022). Immune evasion and provocation by Mycobacterium tuberculosis. Nature Reviews Microbiology, 20(12), 750-766. |
[9] | Kirimi, E. M., Muthuri, G. G., Ngari, C. G., & Karanja, S. (2024). Modeling the effects of vaccine efficacy and rate of vaccination on the transmission of pulmonary tuberculosis. Informatics in Medicine Unlocked, 46, 101470. |
[10] | Kirimi, E. M., Muthuri, G. G., Ngari, C. G., & Karanja, S. (2024). A Model for the Propagation and Control of Pulmonary Tuberculosis Disease in Kenya. Discrete Dynamics in Nature and Society, 2024(1), 5883142. |
[11] | Li, Q., & Wang, F. (2023). An epidemiological model for tuberculosis considering environmental transmission and reinfection. Mathematics, 11(11), 2423. |
[12] | Alfiniyah, C., Soetjianto, W. S. P. A., Aziz, M. H. N., & Ghadzi, S. M. B. S. (2024). Mathematical modeling and optimal control of tuberculosis spread among smokers with case detection. AIMS Mathematics, 9(11), 30472-30492. |
[13] | Xu, C., Cheng, K., Guo, S., Yuan, D., & Zhao, X. (2024). A dynamic model to study the potential TB infections and assessment of control strategies in China. arXiv preprint arXiv: 2401.12462. |
[14] | Wang, J., & Lyu, G. (2024). Analysis of an age‐space structured tuberculosis model with treatment and relapse. Studies in Applied Mathematics, 153(1), e12700. |
[15] | Oshinubi, K., Peter, O. J., Addai, E., Mwizerwa, E., Babasola, O., Nwabufo, I. V.,... & Agbaje, J. O. (2023). Mathematical modelling of tuberculosis outbreak in an East African country incorporating vaccination and treatment. Computation, 11(7), 143. |
[16] | Kasereka, S. K. (2024). Dynamics of a Tuberculosis Outbreak Model in a Multi-scale Environment. arXiv preprint arXiv: 2411.04297. |
[17] | Ochieng, F. O. (2025). Mathematical Modeling of Tuberculosis Transmission Dynamics With Reinfection and Optimal Control. Engineering Reports, 7(1), e13068. |
[18] | Njeri, A. W., Kanyiri, C., & Okwanyi, I. (2024). Mathematical Analysis of Pneumonia Dynamics with Misdiagnosis. Journal of African Interdisciplinary Studies, 8(8), 238-255. |
[19] | Chukwu, C. W., Tchoumi, S. Y., & Diagne, M. L. (2024). A simulation study to assess the epidemiological impact of pneumonia transmission dynamics in high-risk populations. Decision Analytics Journal, 10, 100423. |
[20] | Ndendya, J. Z., & Liana, Y. A. (2024). Mathematical Model and Analysis of Pneumonia on Children under five years with Malnutrition. Available at SSRN 4692559. |
[21] | Mumbu, A. (2024). Modeling dynamics and stability analysis of pneumonia disease infection with parameters uncertainties control. Mathematics Open, 3, 2430001. |
[22] | Aldila, D., Awdinda, N., Herdicho, F. F., Ndii, M. Z., & Chukwu, C. W. (2023). Optimal control of pneumonia transmission model with seasonal factor: learning from Jakarta incidence data. Heliyon, 9(7). |
[23] | Tilahun, G. T., Makinde, O. D., & Malonza, D. (2017). Modelling and optimal control of pneumonia disease with cost-effective strategies. Journal of biological dynamics, 11(sup2), 400-426. |
[24] | Olopade, I. A., Akinola, E. I., Philemon, M. E., Mohammed, I. T., Ajao, S. O., Sangoniyi, S. O., & Adeniran, G. A. (2024). Modeling the mathematical transmission of a pneumonia epidemic model with awareness. Journal of Applied Sciences and Environmental Management, 28(2), 403-413. |
[25] |
Shrestha, S., & Shrestha, A. (2024). Mathematical modelling to accurately quantify the benefits of pneumococcal conjugate vaccine. The Lancet Global Health, 12(9), e1377-e1378.
https://www.thelancet.com/action/showPdf?pii=S2214-109X%2824%2900323-1 |
[26] | Yano, T. K., & Bitok, J. (2022). Computational Modelling of Pneumonia Disease Transmission Dynamics with Optimal Control Analysis. Appl. Comput. Math, 11(5), 130-139. |
[27] |
World Health Organization. (2025). Report of the WHO consultation on asymptomatic tuberculosis, Geneva, Switzerland, 14-15 October 2024. Retrieved May 4, 2025, from
https://iri s.who.int/bitstream/handle/10665/380616/9789240106932-eng.pdf |
[28] |
World Health Organization. (2025). Integrated approach to tuberculosis and lung health: Policy brief. Geneva: World Health Organization. Licence: CC BY-NC-SA 3.0 IGO. Retrieved May 14, 2025, from
https://iris.who.int/bitstream/handle/10665/380840/9789240107526-eng.pdf%20?sequence=1 |
[29] | Banerjee, S. (2021). Mathematical modeling: models, analysis and applications. Chapman and Hall/CRC. |
[30] | Kizito, M., Nampala, H., & Ariho, P. (2024). Mathematical Modelling of Tuberculosis and Hepatitis C Coinfection Dynamics with No Intervention. Journal of Mathematics, 2024(1), 5521979. |
[31] | Khajanchi, S., Das, D. K., & Kar, T. K. (2018). Dynamics of tuberculosis transmission with exogenous reinfections and endogenous reactivation. Physica A: Statistical Mechanics and its Applications, 497, 52-71. |
[32] | Driessche, K., Khajanchi, S., & Kar, T. K. (2020). Transmission dynamics of tuberculosis with multiple re-infections. Chaos, Solitons & Fractals, 130, 109450. |
[33] | La Salle, J. P. (1976). The stability of dynamical systems. Society for Industrial and Applied Mathematics. |
[34] | Khajanchi, S., Bera, S., & Roy, T. K. (2021). Mathematical analysis of the global dynamics of a HTLV-I infection model, considering the role of cytotoxic T-lymphocytes. Mathematics and Computers in Simulation, 180, 354-378. |
[35] | Chowell, G., & Kiskowski, M. (2016). Modeling ring-vaccination strategies to control Ebola virus disease epidemics. Mathematical and statistical modeling for emerging and re-emerging infectious diseases, 71-87. |
[36] |
KNBS 2023. Statistical Abstract 2023. Nairobi, Kenya. Retrieved May 21, 2025, from
https://www.knbs.or.ke/wp-content/uploads/2023/11/2023-Statistical-Abstract.pdf |
[37] | National Tuberculosis, Leprosy and Lung Disease Program. National strategic plan for tuberculosis, leprosy and lung health 2019-2023. Ministry of Health, Kenya. Retrieved May 23, 2025, from |
[38] | National Tuberculosis, Leprosy and Lung Disease Program. 2021 Annual Report. Ministry of Health, Kenya. Retrieved May 26, 2025, from |
[39] | National Tuberculosis, Leprosy and Lung Disease Program. Kenya latent tuberculosis infection policy 2020. Ministry of health, Kenya. Retrieved May 21, 2025, from |
[40] | National Tuberculosis, Leprosy and Lung Disease Program. 2022 Annual Report. Ministry of Health, Kenya. Retrieved May 21, 2025, from |
APA Style
Kirimi, E. M., Okelo, J., Kimathi, M., Ngure, K. (2025). Pulmonary Tuberculosis and Pneumonia Co-Dynamics: A Mathematical Modelling Approach. Applied and Computational Mathematics, 14(4), 223-241. https://doi.org/10.11648/j.acm.20251404.15
ACS Style
Kirimi, E. M.; Okelo, J.; Kimathi, M.; Ngure, K. Pulmonary Tuberculosis and Pneumonia Co-Dynamics: A Mathematical Modelling Approach. Appl. Comput. Math. 2025, 14(4), 223-241. doi: 10.11648/j.acm.20251404.15
@article{10.11648/j.acm.20251404.15, author = {Erick Mutwiri Kirimi and Jeconiah Okelo and Mark Kimathi and Kenneth Ngure}, title = {Pulmonary Tuberculosis and Pneumonia Co-Dynamics: A Mathematical Modelling Approach }, journal = {Applied and Computational Mathematics}, volume = {14}, number = {4}, pages = {223-241}, doi = {10.11648/j.acm.20251404.15}, url = {https://doi.org/10.11648/j.acm.20251404.15}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.acm.20251404.15}, abstract = {This study presents a novel mathematical model that captures the co-dynamics of pulmonary tuberculosis in the presence of opportunistic pneumonia. The model integrates opportunistic pneumonia into the classical pulmonary tuberculosis transmission framework, based on clinical evidence of a lethal synergism between the two diseases. A Holling-type saturation function is utilized to reflect the impact of natural immunity on the progression from latent tuberculosis infection to active disease. Asymptomatic infectious individuals can transmit the infection unnoticed, thereby significantly contributing to the high rate of transmission. Thus, the screening of asymptomatic individuals is incorporated into the model as a strategy to mitigate the prevalence of co-infections. A comprehensive sensitivity analysis and numerical simulations were conducted to evaluate the effects of various interventions, including enhancing natural immunity, screening asymptomatic and latently infected individuals, improving vaccine efficacy, and treating patients with severe pulmonary tuberculosis. The sensitivity analysis reveals that improving vaccine efficacy is the most effective strategy for minimizing co-infections. Simulations also demonstrate that increased screening and treatment rates significantly reduce the burden of pulmonary tuberculosis-pneumonia co-infections. These results underscore the need to develop vaccines with higher efficacy to reduce co-infections of pulmonary tuberculosis and opportunistic pneumonia. Additionally, the study recommends expanded screening of asymptomatic tuberculosis cases and the strengthening of immunity among latently infected populations.}, year = {2025} }
TY - JOUR T1 - Pulmonary Tuberculosis and Pneumonia Co-Dynamics: A Mathematical Modelling Approach AU - Erick Mutwiri Kirimi AU - Jeconiah Okelo AU - Mark Kimathi AU - Kenneth Ngure Y1 - 2025/08/20 PY - 2025 N1 - https://doi.org/10.11648/j.acm.20251404.15 DO - 10.11648/j.acm.20251404.15 T2 - Applied and Computational Mathematics JF - Applied and Computational Mathematics JO - Applied and Computational Mathematics SP - 223 EP - 241 PB - Science Publishing Group SN - 2328-5613 UR - https://doi.org/10.11648/j.acm.20251404.15 AB - This study presents a novel mathematical model that captures the co-dynamics of pulmonary tuberculosis in the presence of opportunistic pneumonia. The model integrates opportunistic pneumonia into the classical pulmonary tuberculosis transmission framework, based on clinical evidence of a lethal synergism between the two diseases. A Holling-type saturation function is utilized to reflect the impact of natural immunity on the progression from latent tuberculosis infection to active disease. Asymptomatic infectious individuals can transmit the infection unnoticed, thereby significantly contributing to the high rate of transmission. Thus, the screening of asymptomatic individuals is incorporated into the model as a strategy to mitigate the prevalence of co-infections. A comprehensive sensitivity analysis and numerical simulations were conducted to evaluate the effects of various interventions, including enhancing natural immunity, screening asymptomatic and latently infected individuals, improving vaccine efficacy, and treating patients with severe pulmonary tuberculosis. The sensitivity analysis reveals that improving vaccine efficacy is the most effective strategy for minimizing co-infections. Simulations also demonstrate that increased screening and treatment rates significantly reduce the burden of pulmonary tuberculosis-pneumonia co-infections. These results underscore the need to develop vaccines with higher efficacy to reduce co-infections of pulmonary tuberculosis and opportunistic pneumonia. Additionally, the study recommends expanded screening of asymptomatic tuberculosis cases and the strengthening of immunity among latently infected populations. VL - 14 IS - 4 ER -